Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) EPS (Basic): HK$0.47 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03613 Beijing Tong Ren Tang Chinese Medicine Co Ltd HKSE:03613
89 GF Score
Price HK$6.90
GF Value HK$9.64
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Beijing Tong Ren Tang Chinese Medicine Co EPS (Basic)?

Beijing Tong Ren Tang Chinese Medicine Co HKSE:03613 -1.85% 89 EPS (Basic) is HK$0.47 as of Dec. 2025. GuruFocus rates HKSE:03613 with a GF Score™ of 89/100 and a GF Value™ of HK$9.64 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Beijing Tong Ren Tang Chinese Medicine Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was HK$0.19. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.47.

Beijing Tong Ren Tang Chinese Medicine Co's EPS (Diluted) for the six months ended in Dec. 2025 was HK$0.19. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.47.

Beijing Tong Ren Tang Chinese Medicine Co's EPS without NRI for the six months ended in Dec. 2025 was HK$0.25. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 0.53.

During the past 12 months, Beijing Tong Ren Tang Chinese Medicine Co's average EPS without NRIGrowth Rate was -10.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -11.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was -4.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Beijing Tong Ren Tang Chinese Medicine Co's highest 3-Year average EPS without NRI Growth Rate was 57.70% per year. The lowest was -11.70% per year. And the median was 5.50% per year.

Beijing Tong Ren Tang Chinese Medicine Co  (HKSE:03613) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Beijing Tong Ren Tang Chinese Medicine Co EPS (Basic) Related Terms

Beijing Tong Ren Tang Chinese Medicine Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Beijing Tong Ren Tang Chinese Medicine Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tong Ren Tang Chinese Medicine Co EPS (Basic) Chart

Beijing Tong Ren Tang Chinese Medicine Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.73 0.77 0.65 0.60 0.47

Beijing Tong Ren Tang Chinese Medicine Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.26 0.34 0.28 0.19
HKSE:03613
89GF Score
Beijing Tong Ren Tang Chinese Medicine Co Ltd HKSE:03613
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Tong Ren Tang Chinese Medicine Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Beijing Tong Ren Tang Chinese Medicine Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(397.216-0)/837.100
=0.47

Beijing Tong Ren Tang Chinese Medicine Co's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(162.35-0)/837.100
=0.19

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of HK$0.47 mean?
Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) has a EPS (Basic) of HK$0.47 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Beijing Tong Ren Tang Chinese Medicine Co and its competitors.
Is Beijing Tong Ren Tang Chinese Medicine Co's EPS (Basic) too high?
Beijing Tong Ren Tang Chinese Medicine Co's current EPS (Basic) is HK$0.47. Overall, Beijing Tong Ren Tang Chinese Medicine Co has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tong Ren Tang Chinese Medicine Co's EPS (Basic) compare to ZTS and UTHR?
Beijing Tong Ren Tang Chinese Medicine Co's EPS (Basic) of HK$0.47 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Beijing Tong Ren Tang Chinese Medicine Co and its competitors. Beijing Tong Ren Tang Chinese Medicine Co's current EPS (Basic) is HK$0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tong Ren Tang Chinese Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$9.64, compared to a current price of HK$6.90 — trading 28.4% below its estimated fair value. The current EPS (Basic) is HK$0.47. Beijing Tong Ren Tang Chinese Medicine Co's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613), the current EPS (Basic) is HK$0.47 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tong Ren Tang Chinese Medicine Co stock appears to be undervalued. The current stock price of HK$6.90 is trading 28.4% below its estimated GF Value™ of HK$9.64. GuruFocus considers Beijing Tong Ren Tang Chinese Medicine Co to be Modestly Undervalued.

Key valuation signals for HKSE:03613:

  • EPS (Basic): HK$0.47
  • GF Value™: HK$9.64 vs. price of HK$6.90 (28.4% below fair value)
  • GF Score™: 89/100 with 3 warning signs

No single metric tells the full story. See the HKSE:03613 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Tong Ren Tang Chinese Medicine Co Business Description

Other Exchanges TQR:Germany
Address Convention Plaza, 1 Harbour Road, Room 1405-1409, Office Tower, Wanchai, Hong Kong, HKG
Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products; Chinese Mainland (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Chinese Mainland and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd; and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.
89GF Score

Get the complete analysis for HKSE:03613

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.90
Price
HK$9.64
GF Value